Comparison between metformin and intermittent fasting for renoprotective effects through mitophagy modulation in a rat cisplatin-induced acute kidney injury model
Abstract
The current study investigated the effects of metformin versus intermittent fasting as modulators of mitophagy in cisplatin-induced acute renal injury in rats. Twenty-four adult male rats were divided into four groups: control, cisplatin, metformin-treated, and intermittent fasting groups. Cisplatin (8 mg/kg, intraperitoneal) was administered once on day eight, while metformin (200 mg/kg) was given orally for 12 days. Renal function parameters including serum creatinine, blood urea nitrogen (BUN), fractional excretion of sodium (FENa), and serum sodium and potassium levels were measured, along with urinary neutrophil gelatinase associated lipocalin (NGAL) and renal oxidative stress markers malondialdehyde and superoxide dismutase (MDA and SOD). Mitophagy was assessed by immunohistochemical evaluation of Microtubule-Associated Protein 1 Light Chain and Nucleoporin p62 (LC3 and p62) expression, measurement of PTEN-induced kinase 1(PINK1) levels, and Parkin gene expression, along with histopathological examination of renal tissues. Cisplatin administration significantly impaired kidney function, increased oxidative stress and p62 expression, and reduced SOD, LC3, PINK1, and Parkin gene expression, accompanied by marked histopathological renal damage. Treatment with metformin or intermittent fasting significantly improved renal function tests, reduced oxidative stress and p62 levels, and restored LC3, PINK1, and Parkin expression, with corresponding improvement in renal histopathology. These findings suggest that metformin and intermittent fasting exert protective effects against cisplatin-induced acute kidney injury, potentially through modulation of oxidative stress and mitophagy pathways.
Related
- Metformin improves mitophagy-related pathways and mitochondrial-lysosomal homeostasis in chromosome 21 trisomic fibroblasts.
- Severe Suspected Metformin-Associated Lactic Acidosis With Relatively Preserved Serum Creatinine at Presentation: Sequential Intermittent Hemodialysis and Continuous Venovenous Hemodialysis.
- Renoprotective effects of dapagliflozin and montelukast for diclofenac induced acute kidney injury through network pharmacology and experimental validation
- Renoprotective vs. Antihypertensive Dosing of Renin–Angiotensin System Inhibitors in Chronic Kidney Disease: Analysis of Summary of Product Characteristics of Medicinal Products Authorized in Poland
- Real-world renoprotective effects of polyethylene glycol-loxenatide in type 2 diabetes: a multicenter, ambispective cohort study.
BibTeX
@article{elmorshdy2026comparison,
title = {{Comparison between metformin and intermittent fasting for renoprotective effects through mitophagy modulation in a rat cisplatin-induced acute kidney injury model}},
author = {Shorouk E. M. Elmorshdy and Doaa Genedy and Nora Elshehawy Helal and Abdelrahman H. K. Moustafa and Reem M. Emam},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-73001-z},
url = {https://www.nature.com/articles/s41598-026-73001-z},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Comparison between metformin and intermittent fasting for renoprotective effects through mitophagy modulation in a rat cisplatin-induced acute kidney injury model
AU - Shorouk E. M. Elmorshdy
AU - Doaa Genedy
AU - Nora Elshehawy Helal
AU - Abdelrahman H. K. Moustafa
AU - Reem M. Emam
PY - 2026
DA - 2026/10/23
JO - Scientific Reports
DO - 10.1038/s41598-026-73001-z
UR - https://www.nature.com/articles/s41598-026-73001-z
AB - The current study investigated the effects of metformin versus intermittent fasting as modulators of mitophagy in cisplatin-induced acute renal injury in rats. Twenty-four adult male rats were divided into four groups: control, cisplatin, metformin-treated, and intermittent fasting groups. Cisplatin (8 mg/kg, intraperitoneal) was administered once on day eight, while metformin (200 mg/kg) was given orally for 12 days. Renal function parameters including serum creatinine, blood urea nitrogen (BUN), fractional excretion of sodium (FENa), and serum sodium and potassium levels were measured, along with urinary neutrophil gelatinase associated lipocalin (NGAL) and renal oxidative stress markers malondialdehyde and superoxide dismutase (MDA and SOD). Mitophagy was assessed by immunohistochemical evaluation of Microtubule-Associated Protein 1 Light Chain and Nucleoporin p62 (LC3 and p62) expression, measurement of PTEN-induced kinase 1(PINK1) levels, and Parkin gene expression, along with histopathological examination of renal tissues. Cisplatin administration significantly impaired kidney function, increased oxidative stress and p62 expression, and reduced SOD, LC3, PINK1, and Parkin gene expression, accompanied by marked histopathological renal damage. Treatment with metformin or intermittent fasting significantly improved renal function tests, reduced oxidative stress and p62 levels, and restored LC3, PINK1, and Parkin expression, with corresponding improvement in renal histopathology. These findings suggest that metformin and intermittent fasting exert protective effects against cisplatin-induced acute kidney injury, potentially through modulation of oxidative stress and mitophagy pathways.
SN - 2045-2322
ER -